致心律失常性心肌病先证者与家族成员的外显率及疾病进展相似
该纵向队列研究纳入144例致心律失常性心肌病(AC)患者及突变阳性家族成员,评估结构进展及其对心律失常结局的影响。结果显示入组时58%家族成员已符合AC诊断标准,随访期间未患病家族成员年新外显率为8%;先证者与家族成员的结构进展速率相似,结构进展与严重室性心律失常事件风险显著升高相关(HR 21.24)。
要点
- 家族成员在基因诊断时AC外显率已达58%,随访中年新外显率为8%。
- 先证者与家族成员的结构进展速率相似,右室流出道直径年进展约0.5–0.6 mm。
- 结构进展与严重室性心律失常事件风险显著升高相关(HR 21.24)。
核心结论
- 超过半数家族成员在基因诊断时已符合AC标准,年外显率为8%。
- 先证者与家族成员的结构进展速率相似,结构进展与严重室性心律失常事件风险升高相关。
研究设计与样本
- 纵向队列研究,纳入144例AC患者及家族成员(48%女性,47%先证者,年龄40±16岁)。
- 结构进展定义为从入组至随访出现新的Task Force影像学标准,进展速率定义为影像参数的年变化。
- 随访时间7.0年(IQR 4.5–9.4),基于598次超声心动图检查分析。
主要发现
- 入组时58%的家族成员已符合AC诊断标准。
- 随访期间47%的入组时无AC的家族成员出现AC标准,年新外显率为8%。
- 先证者与家族成员右室流出道直径年进展速率相似(0.5 mm/年 vs 0.6 mm/年,P=0.28)。
- 家族成员右室面积变化分数年进展速率更高(-0.6%/年 vs -0.8%/年,P<0.01)。
- 入组时无明确结构病变或心律失常史的86例患者中,8例(9%)发生首次严重室性心律失常事件,其中7例(88%)伴结构进展;结构进展与严重室性心律失常事件风险升高相关(HR 21.24,95%CI 2.47–182.81,P<0.01,校正年龄、性别及先证者状态)。
关键数值与推荐
- 结构进展定义为从入组至随访出现新的Task Force影像学标准。
- 进展速率定义为影像参数的年变化。
临床怎么用
- 对突变阳性家族成员应定期进行影像学筛查以评估AC外显及结构进展。
- 结构进展可提示严重室性心律失常事件风险升高,需加强心律失常监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: We aimed to assess structural progression in arrhythmogenic cardiomyopathy (AC) patients and mutation-positive family members and its impact on arrhythmic outcome in a longitudinal cohort study. METHODS AND RESULTS: Structural progression was defined as the development of new Task Force imaging criteria from inclusion to follow-up and progression rates as annual changes in imaging parameters. We included 144 AC patients and family members (48% female, 47% probands, 40 ± 16 years old). At genetic diagnosis and inclusion, 58% of family members had penetrant AC disease. During 7.0 [inter-quartile range (IQR) 4.5-9.4] years of follow-up, 47% of family members without AC at inclusion developed AC criteria, resulting in a yearly new AC penetrance of 8%. Probands and family members had a similar progression rate of right ventricular outflow tract diameter (0.5 mm/year vs. 0.6 mm/year, P = 0.28) by mixed model analysis of 598 echocardiographic examinations. Right ventricular fractional area change progression rate was even higher in family members (-0.6%/year vs. -0.8%/year, P < 0.01). Among 86 patients without overt structural disease or arrhythmic history at inclusion, a first severe ventricular arrhythmic event occurred in 8 (9%), of which 7 (88%) had concomitant structural progression. Structural progression was associated with higher incidence of severe ventricular arrhythmic events adjusted for age, sex, and proband status (HR 21.24, 95% CI 2.47-182.81, P < 0.01). CONCLUSION: More than half of family members had AC criteria at genetic diagnosis and yearly AC penetrance was 8%. Structural progression was similar in probands and family members and was associated with higher incidence of severe ventricular arrhythmic events.
引用
- Chivulescu M, Lie ØH, Popescu BA, et al. High penetrance and similar disease progression in probands and in family members with arrhythmogenic cardiomyopathy. Eur Heart J. 2020. PMID: 31504415. doi:10.1093/eurheartj/ehz570
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。